Tech Company Financing Transactions

Sorbent Therapeutics Funding Round

Sorbent Therapeutics closed a $21.8 million Series B venture capital round on 9/13/2010. Investors included AgeChem Venture Fund, Arch Venture Partners and Dow Venture Capital.

Transaction Overview

Company Name
Sorbent Therapeutics
Announced On
9/13/2010
Transaction Type
Venture Equity
Amount
$21,800,000
Round
Series B
Investors

AgeChem Venture Fund (Nancy Hsiung)

Arch Venture Partners (Scott Minick)

Dow Venture Capital

Presidio Partners (David Collier)

Sofinnova Ventures (James Healy)

Proceeds Purpose
Sorbent will use the capital to advance the clinical development of its lead drug candidate CLP-1001 for patients with sodium and fluid overload or risk for hyperkalemia in renal and cardiovascular diseases, such as End Stage Renal Disease and Congestive Heart Failure.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
710 Lakeway Dr. 290
Sunnyvale, CA 94085
USA
Phone
(408) 738-8240
Website
www.sorbentrx.com
Email Address
[email protected]
Overview
Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.
Profile
Sorbent Therapeutics LinkedIn Company Profile
Social Media
Sorbent Therapeutics Company Twitter Account
Company News
Sorbent Therapeutics News
Facebook
Sorbent Therapeutics on Facebook
YouTube
Sorbent Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Detlef Albrecht
  Detlef Albrecht LinkedIn Profile  Detlef Albrecht Twitter Account  Detlef Albrecht News  Detlef Albrecht on Facebook
Chief Financial Officer
Tom O'Neil
  Tom O'Neil LinkedIn Profile  Tom O'Neil Twitter Account  Tom O'Neil News  Tom O'Neil on Facebook
Chief Medical Officer
Howard Dittrich
  Howard Dittrich LinkedIn Profile  Howard Dittrich Twitter Account  Howard Dittrich News  Howard Dittrich on Facebook
VP - Bus. Development
Linda De Young
  Linda De Young LinkedIn Profile  Linda De Young Twitter Account  Linda De Young News  Linda De Young on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/12/2010: vWise venture capital transaction
Next: 9/13/2010: Sonatype venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.